Pharmaceuticals, Biotechnology and Life Sciences
LAVAL, Quebec–(BUSINESS WIRE)–#Bioavailability–Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is a beta-3 adrenergic receptor (β3) agonist, for the treatm…
First study designed to support marketing authorization of a surgical mesh for use in breast reconstruction
CHICAGO–(BUSINESS WIRE)–SIA (Surgical Innovation Associates), an early growth-stage medical technology company, announced today that the firs…
The prestigious recognition shines a spotlight on the industry’s sharpest, most creative young talent working in medical marketing.
CRANBURY, N.J.–(BUSINESS WIRE)–#MMM40Under40–MJH Life Sciences™ is excited to announce that Michael J. Hennessy Jr.,…
DUBLIN–(BUSINESS WIRE)–The “Animal Blood Plasma Products and Derivatives – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
The publisher brings years of research experience to the 7th edition of …
SAN FRANCISCO, CA & RALEIGH, NC–(BUSINESS WIRE)–Quantum Leap Healthcare Cooperative (Quantum Leap) and SignalPath announced a partnership today that will further empower the I-SPY platform trials with robust, streamlined technology infrastructure to …
Biotech executive Geoff Nosrati, Ph.D. has been named Chief Business Officer as the company expands to San Diego to accommodate growing list of U.S. partnerships
SINGAPORE & SAN DIEGO–(BUSINESS WIRE)–ImmunoScape, a biotech company with an immunomics…
SAN FRANCISCO–(BUSINESS WIRE)–#MBCBiolabs–Florica Therapeutics, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,678 to work on the Hypothalamus Stem Cell Exosomes for Treatment of CO…
Phase I/II Clinical Trial to Be Initiated in First Quarter 2021
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#KRASmutation–Elicio Therapeutics, a private biotechnology company developing a pipeline of potent immunotherapies based on its proprietary lymph-node …
Data from the translationally relevant study reported ability of MYMD-1 to inhibit key biomarkers associated with fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD)
Eurofins Discovery human phenotyp…
SAN FRANCISCO–(BUSINESS WIRE)–LARVOL, leading provider of intelligence and data solutions to pharma and life science teams, today welcomes Mark Lagunowich as Vice President, Global Sales.
“We are thrilled to welcome Mark to the team at LARVOL,” said…